Objective Exploring the current research status,research context,evolution,and future research directions of laboratory animal welfare and ethics in China.Methods Literature related to laboratory animal welfare and ethics was collected from journals in the China National Knowledge Infrastructure(CNKI)database from 2001 to 2023.A combination of a qualitative description based on a literature review and CiteSpace visual bibliometric analysis was used to summarize the achievements,hot topics,and directions of laboratory animal welfare and ethics research.Results The literature shows that the overall popularity of research into laboratory animal welfare and ethics is on the rise in China.The hot research topics in this field include basic theories of laboratory animal welfare and ethics,the legislation of laboratory animal welfare and ethics,technologies for improving laboratory animal welfare and ethics,reviews of laboratory animal welfare and ethics,and laboratory animal welfare and ethics education.In response to the ethical issues arising from emerging interdisciplinary fields,continuous innovation is being made via research into this topic.Conclusions Suggestions are put forward regarding changes to the legal system,review mechanisms,education and training,and innovative research using laboratory animals welfare and ethics to provide a reference and guidance on the welfare and ethics of laboratory animals.

Background and objective Epidermal growth factor receptor (EGFR) and KRAS gene are important driver genes of non-small cell lung cancer (NSCLC).The studies are mainly focused on detection ofEGFR gene for advanced NSCLC,and the mutation feature of EGFR and KRAS gene in early NSCLC tissue is unknown.This study aims to investigate the mutations of EGFR and KRAS gene in NSCLC,and the relationship between the genotype and clinicopathologic features.Methods The hotspot mutations in EGFR and KRAS gene in 754 tissue samples of stage Ⅰ-Ⅲa NSCLC from Department of Pathology,Peking Union Medical College Hospital were detected by modified amplification refractory mutation system (ARMS) real-time PCR kit,and analyzed their correlation with clinical variables.Results The hotspot mutation rates in EGFR and KRAS were 34.5％ and 13.1％ respectively,and there were EGFR-KRAS double mutations in 3 samples.The mutation rate of EGFR was higher in females than that in males (39.5％ vs 29.4％,P=0.076),significantly increased in adenocarcinomas (38.7％) compared to that in the other forms of NSCLC (P＜0.01),but still lower than that reported in some Asian studies of advanced adenocarcinoma (-50％).Meanwhile,the mutation rate of KRAS was remarkably higher in males than that in females (16.6％ vs 9％,P=0.048),increased in adenocarcinomas compared to that in the other forms of NSCLC,but the difference was not significant (P=0.268).Samples harbored EGFR mutation were younger than those harbored KRAS mutation (P=0.031,5),and had significant difference in gender between the two groups (P＜0.01).Conclusion The mutation rate of EGFR in stag Ⅰ-Ⅲa NSCLC patients was lower than that in advanced NSCLC patients.And the percentage of the NSCLC patients with EGFRKRAS double mutations is 0.9％.

Objective:To establish a method for preparing urine arsenic quality control samples and verify its uniformity and stability.Methods:Urine samples of healthy adults were collected, concentrated and then freeze-dried using a freeze dryer. The freeze-dried samples were subjected to atomic fluorescence spectrophotometry to determine the arsenic content. The method was verified from the uniformity, stability, determination of different detection methods, and the fixed value of urine arsenic content.Results:The linear correlation coefficient of the standard curve of the method was 0.999 7. The variation coefficients of arsenic content after freeze-dried of urine samples were all < 5%. The uniformity test results showed that there was no statistically significant difference in the arsenic content between bottles of low and high concentration samples ( t = 1.09, 1.53, P > 0.05), and the sample uniformity was good. The stability test results show that the decline rate of the freeze-dried samples of high and low concentrations stored ≤360 days was less than 10%, and the stability was good at room temperature. Atomic fluorescence spectrophotometry and inductively coupled plasma mass spectrometry(ICP-MS) were used for the arsenic content determination of high and low concentration samples, and there was no significant difference between the two methods ( P > 0.05). The results of determination of arsenic content in urine of 14 provinces and 86 cities and counties showed that the low concentration was (0.028 ± 0.002) mg/L and the high concentration was (0.113 ± 0.008) mg/L. Conclusion:The uniformity and stability of the freeze-dried urine arsenic quality control samples can meet the external quality control requirements of the laboratory in endemic disease prevention and monitoring.